1. Ask the Experts: Managing non-small-cell lung cancer with acquired resistance to EGF receptor and ALK inhibitors. (February 2013) Authors: Lee, Siow-Ming; King, Judy Journal: Lung cancer management Issue: Volume 2:Number 1(2013) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Axitinib for the treatment of advanced non-small-cell lung cancer. (September 2013) Authors: King, Judy W; Lee, Siow-Ming Journal: Expert opinion on investigational drugs Issue: Volume 22:Number 6(2013:Jun.) Page Start: 765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Axitinib for the treatment of advanced non-small-cell lung cancer. (September 2013) Authors: King, Judy W; Lee, Siow-Ming Journal: Expert opinion on investigational drugs Issue: Volume 22:Number 6(2013:Jun.) Page Start: 765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinico-pathological features of MET exon 14 mutation positive NSCLC in the UK. (June 2021) Authors: Benafif, Sarah; Greystoke, Alastair; Carter, Mathew; Bulusu, Ramesh; Baijal, Shobhit; Conibear, John; Nintos, Georgios; Papadatos-Pastos, Dionysis; Ahmad, Tanya; Lee, Siow-Ming; Forster, Martin Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy. Issue 7 (2nd July 2015) Authors: Khan, Iftekhar; Morris, Stephen; Hackshaw, Allan; Lee, Siow-Ming Journal: BMJ open Issue: Volume 5:Issue 7(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lung cancer. (July 2015) Authors: Jamal-Hanjani, Mariam; Lee, Siow-Ming Journal: Lung cancer management Issue: Volume 4:Number 3(2015) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lung cancer. (July 2015) Authors: Jamal-Hanjani, Mariam; Lee, Siow-Ming Journal: Lung cancer management Issue: Volume 4:Number 3(2015) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer. (November 2021) Authors: Moore, David A.; Benafif, Sarah; Poskitt, Benjamin; Argue, Stephanie; Lee, Siow-Ming; Ahmad, Tanya; Papadatos-Pastos, Dionysis; Jamal-Hanjani, Mariam; Bennett, Philip; Forster, Martin D. Journal: Lung cancer Issue: Volume 161(2021) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial. Issue 9 (September 2020) Authors: Middleton, Gary; Brock, Kristian; Savage, Joshua; Mant, Rhys; Summers, Yvonne; Connibear, John; Shah, Riyaz; Ottensmeier, Christian; Shaw, Paul; Lee, Siow-Ming; Popat, Sanjay; Barrie, Colin; Barone, Gloria; Billingham, Lucinda Journal: Lancet Issue: Volume 8:Issue 9(2020) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Precision thoracic oncology in the UK: a two-step NGS pathway for extended molecular profiling in NSCLC. (June 2021) Authors: Moore, David; Benafif, Sarah; Bennett, Philip; Argue, Stephanie; Lee, Siow-Ming; Ahmad, Tanya; Papadatos-Pastos, Dionysis; Forster, Martin Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗